Metronomic Chemotherapy: A Novel Approach in Cancer Treatment
Metronomic chemotherapy presents a novel and effective strategy in oncology, with the potential to overcome limitations of traditional chemotherapy. By consolidating current evidence and clinical insights, this review supports the broader adoption of MCT and offers recommendations for optimizing its use in future cancer treatment protocols.
Authors
- Kumaraswamy Dabburu (ORCID: https://orcid.org/0009-0004-7226-0538)
- Mangal Charan Murmu (ORCID: https://orcid.org/0000-0003-2606-6545)
- S. Ghosh (ORCID: https://orcid.org/0000-0001-9927-0059)
- Balaji Nagarajan (ORCID: https://orcid.org/0000-0003-3892-6178)
- Tabinda Hasan (ORCID: https://orcid.org/0000-0001-6886-6220)
- Swetha Raparla
- Rajkumar Krishnan Vasanthi (ORCID: https://orcid.org/0000-0001-6866-8224)
- K. Raja
- Hari Kumar Kuragayala
- S Shamina
Institutions
- Princess Nourah bint Abdulrahman University (SA)
- INTI International University (MY)
- Government Medical College (IN)
- Department of Biotechnology (IN)
- Mohammed Bin Rashid University of Medicine and Health Sciences (AE)
- Ross University School of Medicine (BB)
- Windsor Dermatology (US)
- Barbados Community College (BB)
- Thermo Fisher Scientific (United States) (US)
- Thermo Fisher Scientific (Israel) (IL)
- Dr. Hari Singh Gour University (IN)
Publication Details
- Journal
- Asian Pacific Journal of Cancer Prevention
- Published
- 2025-10-01
- DOI
- https://doi.org/10.31557/apjcp.2025.26.10.3849
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00